Skip to main content
Contact Us
Subscribe
E-Edition
30°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Natera Inc
(NQ:
NTRA
)
169.17
-0.65 (-0.38%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Natera Inc
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Looking Into Natera's Recent Short Interest
December 02, 2024
Via
Benzinga
Clinical Validation Study on Natera’s Fetal RhD NIPT Published in Obstetrics & Gynecology
December 02, 2024
From
Natera, Inc.
Via
Business Wire
Natera Announces Medicare Coverage for Prospera™ in Single Lung Transplant Recipients
November 27, 2024
From
Natera, Inc.
Via
Business Wire
Natera to Present New SignateraTM Data in Multiple Abstracts at the San Antonio Breast Cancer Symposium
November 25, 2024
From
Natera, Inc.
Via
Business Wire
Analyst Expectations For Natera's Future
November 18, 2024
Via
Benzinga
Natera Issues Statement on Guardant Health Litigation
November 25, 2024
From
Natera, Inc.
Via
Business Wire
Natera Co-Founder and Executive Chairman Matthew Rabinowitz Named 2024 R&D Leader of the Year
November 25, 2024
From
Natera, Inc.
Via
Business Wire
Natera Announces Publication of over 100 Peer-Reviewed Papers on SignateraTM
November 21, 2024
From
Natera, Inc.
Via
Business Wire
Here Are Billionaire Stanley Druckenmiller's 5 Biggest Stock Holdings
November 21, 2024
Via
The Motley Fool
Natera Analysts Increase Their Forecasts Following Upbeat Results
November 13, 2024
Via
Benzinga
Earnings Scheduled For November 12, 2024
November 12, 2024
Via
Benzinga
How Is The Market Feeling About Natera?
November 05, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 13, 2024
Via
Benzinga
Stocks Edge Higher, Dollar Hits 1-Year Peak, Bitcoin Soars To $93,000: What's Driving Markets Wednesday?
November 13, 2024
Wall Street rebounds on inflation report, with consumer discretionary and real estate sectors leading. Senator John Thune elected majority leader. U.S. dollar hits 1-year high.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Paymentus Posts Better-Than-Expected Earnings, Joins Dave, Honest Company, Natera, CAVA Group And Other Big Stocks Moving Higher On Wednesday
November 13, 2024
Via
Benzinga
Exploring NASDAQ:NTRA's high growth characteristics.
November 04, 2024
NATERA INC (NASDAQ:NTRA) is a candidate for high growth investors. Here's why.
Via
Chartmill
Evaluating Natera: Insights From 10 Financial Analysts
October 16, 2024
Via
Benzinga
Why the high growth investor may take a look at NATERA INC (NASDAQ:NTRA).
October 07, 2024
Why the high growth investor may take a look at NATERA INC (NASDAQ:NTRA).
Via
Chartmill
Starbucks To $77? Here Are 10 Top Analyst Forecasts For Wednesday
November 13, 2024
Via
Benzinga
Natera Reports Third Quarter 2024 Financial Results
November 12, 2024
From
Natera, Inc.
Via
Business Wire
Stocks Fall On Tariffs Fears, Dollar Hits 6-Month Peak, Yen Tumbles: What's Driving Markets Tuesday?
November 12, 2024
Wall Street saw the first surge in risk aversion after Donald Trump's election victory last week, as concerns grew over potential tariffs and trade policy shifts spurred by the incoming...
Via
Benzinga
Topics
Government
World Trade
Exposures
Political
Tariff
Natera Announces Completion of Signatera™ Analysis from the CALGB (Alliance)/SWOG 80702 Randomized, Phase III Clinical Trial in Colorectal Cancer
November 12, 2024
From
Natera, Inc.
Via
Business Wire
3 Under-the-Radar Healthcare Companies
November 11, 2024
While established healthcare firms are among the most stable stocks in the sector, up-and-coming companies can offer the potential for greater gains.
Via
MarketBeat
Natera to Participate in Upcoming Investor Conferences
November 08, 2024
From
Natera, Inc.
Via
Business Wire
Smaller Cap Biotechs Are In Season: How Are We Doing?
November 07, 2024
SMID biotech stocks still see a lot of speculative interest except for a brief sell-off on August 5 when the XBI touched $91.The XBI is near its 2024 high in the $103 range.
Via
Talk Markets
Natera to Report its Third Quarter 2024 Results on November 12, 2024
November 01, 2024
From
Natera, Inc.
Via
Business Wire
Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500
October 31, 2024
The Ark Innovation and Ark Genomic ETFs turn ten years old. A look at the annual returns and current top holdings.
Via
Benzinga
Topics
ETFs
Stocks
Exposures
US Equities
Natera to Present New Renasight Data at ASN Kidney Week 2024
October 22, 2024
From
Natera, Inc.
Via
Business Wire
Blue Skies, New Highs Remain Disciplined And Do Not Chase Extended Ideas
October 13, 2024
It is Fall clean up time. Sell lagging and sagging companies.
Via
Talk Markets
A Biotech Breakout Will Be Led By Small Caps
September 23, 2024
It’s hard to focus on biotech stocks right now because there are many distractions. The Fed and the rate cuts, AI and semiconductor stocks and geopolitical turmoil seemingly worse than ever.
Via
Talk Markets
Topics
Artificial Intelligence
Economy
Exposures
Artificial Intelligence
Interest Rates
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.